Trial Profile
A Phase II Study of oc000459 in Subjects With Allergic Asthma; a Randomised, Double Blind, Two Way Balanced Crossover Comparing oc000459 With Placebo.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 06 Aug 2019
Price :
$35
*
At a glance
- Drugs Timapiprant (Primary)
- Indications Allergic asthma
- Focus Therapeutic Use
- Sponsors Oxagen
- 03 Feb 2010 New trial record